Kolexia
Parant Francois
Pharmacien
Hôpital Lyon Sud
Pierre-Bénite, France
56 Activités
230 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Dégénérescence hépatolenticulaire COVID-19 Insuffisance rénale chronique Pneumopathie infectieuse Syndrome néphrotique Maladies transmissibles Maladies musculaires Poumon éosinophile

Industries

Adliva
23 collaboration(s)
Dernière en 2021
ViiV Healthcare
11 collaboration(s)
Dernière en 2023
Gilead
8 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2023

Dernières activités

Biomarkers for the diagnosis and monitoring of nitrous oxide intoxication: objectives and methodology of the SFBC Working Group.
Annales de biologie clinique   26 février 2024
Daptomycin pharmacokinetic/pharmacodynamic target in staphylococcal infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   17 janvier 2024
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
British journal of clinical pharmacology   21 août 2023
Clinical improvement after Essure® devices removal: a systematic review.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception   19 juillet 2023
Daptomycin Exposure as a Risk Factor for Daptomycin-Induced Eosinophilic Pneumonia and Muscular Toxicity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   19 juin 2023
Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping.
ESMO open   31 mai 2023
Minerals and Antioxidant Micronutrients Levels and Clinical Outcome in Older Patients Hospitalized for COVID-19 during the First Wave of the Pandemic.
Nutrients   21 mars 2023
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
The Journal of antimicrobial chemotherapy   03 mars 2023
Evaluation of Limited Sampling Strategies for Bayesian Estimation of Daptomycin Area Under the Concentration-Time Curve: A Short Communication.
Therapeutic drug monitoring   02 janvier 2023
Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants.
Infectious diseases now   31 octobre 2022